Award
National Institute of Allergy and Infectious Diseases 1R01AI192456-01
Engineering durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development
Recipient
SCRIPPS RESEARCH INSTITUTE, THE
Award Amount
$1,379,954.00
Ceiling
$1,379,954.00
Awarded
August 21, 2025
Identifier
1R01AI192456-01
A multiyear NIH grant awarded to Scripps Research Institute to develop an effective HIV vaccine by optimizing vaccine parameters to induce long-lived plasma cells and durable immunity.
Description
The project aims to systematically investigate how different vaccine components and delivery methods influence the immune system's ability to produce durable antibody responses, with the goal of developing an effective HIV vaccine that induces long-lasting protection.